Therapeutic tyrosine kinase inhibitors for multiple sclerosis
US-2026060974-A1 · Mar 5, 2026 · US
Principia Biopharma Inc patents
Principia Biopharma Inc holds 135 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 135 |
| Recent patents | 42 |
| First publication | Jan 27, 2015 |
| Latest publication | Mar 5, 2026 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Therapeutic tyrosine kinase inhibitors for myelin oligodendrocyte glycoprotein antibody disease (mogad)
US-2026027100-A1 · Jan 29, 2026 · US
Methods of Making Modified BTK Inhibitors
US-2026022123-A1 · Jan 22, 2026 · US
Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-yl]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-yl)Piperazin-1-yl]Pent-2-Enenitrile
US-2025381193-A1 · Dec 18, 2025 · US
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
US-2025376471-A1 · Dec 11, 2025 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Therapeutic tyrosine kinase inhibitors for multiple sclerosis
US-2026060974-A1 · Mar 5, 2026 · US
Therapeutic tyrosine kinase inhibitors for myelin oligodendrocyte glycoprotein antibody disease (mogad)
US-2026027100-A1 · Jan 29, 2026 · US
Methods of Making Modified BTK Inhibitors
US-2026022123-A1 · Jan 22, 2026 · US
Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-yl]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-yl)Piperazin-1-yl]Pent-2-Enenitrile
US-2025381193-A1 · Dec 18, 2025 · US
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
US-2025376471-A1 · Dec 11, 2025 · US
Top CPC classifications
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61K31/519 | 92 |
| A61P35/00 | 80 |
| A61P37/00 | 70 |
| A61K45/06 | 64 |
| C07D487/04 | 62 |
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 134 |
| Chemistry & Metallurgy | 101 |
| Physics | 2 |
| Cross-Sectional Technologies | 2 |
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Principia Biopharma Inc have in patentsdb?
- Principia Biopharma Inc is linked to 135 publications as assignee in our database.
- What technology areas does Principia Biopharma Inc patent most?
- Top mapped technology areas by patent count: Human Necessities (134); Chemistry & Metallurgy (101); Physics (2).
- Is Principia Biopharma Inc's patent activity growing?
- In our data, assignee counts were 14 in 2024 and 20 in 2025 (higher year over year).
- What are recent patents assigned to Principia Biopharma Inc?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.